Document:

EX-10.19

 Exhibit 10.19 
 2013 PERFORMANCE RESTRICTED STOCK UNITS 
 GRANT AGREEMENT

 Effective [insert date], 2013 (the “Date of Grant”), the Compensation Committee of the Board of Directors
(the “Committee”) of The Babcock & Wilcox Company ( “B&W”) awarded you a grant of performance-based restricted stock units (“Performance RSUs”) under the 2010 Long-Term Incentive Plan
of B&W, as amended and restated February 22, 2011 (the “Plan”). The provisions of the Plan are incorporated herein by reference. 
 Any reference or definition contained in this Agreement shall, except as otherwise specified, be construed in accordance with the terms and conditions of the Plan and all determinations and
interpretations made by the Committee with regard to any question arising hereunder or under the Plan shall be binding and conclusive on you and your legal representatives and beneficiaries. The term “B&W” as used in this Agreement
with reference to employment shall include subsidiaries of B&W (including unconsolidated joint ventures). Whenever the words “you or your” are used in any provision of this Agreement under circumstances where the provision should
logically be construed to apply to the beneficiary, estate, or personal representative, to whom any rights under this Agreement may be transferred by will or by the laws of descent and distribution, it shall be deemed to include such person.

 Performance RSUs 
 Performance RSU Award. You have been awarded an initial number of performance-based restricted stock units shown on the attached Notice of Grant (the “Initial Performance RSUs”),
which notice is incorporated herein by reference. These Performance RSUs represent a right to receive shares of B&W common stock, calculated as described below, provided the applicable performance measures and vesting requirements set forth in
this Agreement have been satisfied. No shares are awarded or issued to you on the Date of Grant. 
 Vesting Requirements. Subject to the
“Forfeiture of Performance RSUs” provision below, Performance RSUs do not provide you with any rights or interest therein until they become vested under one of the following circumstances (each a “Vesting Date”):

  

	 	•	on the third anniversary of the Date of Grant, provided you are still employed by B&W (with the number in which you vest determined as described in the “Number
of Performance RSUs” provision below); 

  

	 	•	100% of the Initial Performance RSUs shall become vested prior to the third anniversary of the Date of Grant on the earliest to occur of: (1) the date of
termination of your employment from B&W due to death, (2) your disability (as defined in the Plan) or (3) the date a change in control (as defined in the Plan) occurs; and 

 

	 	•	the Committee may provide for additional vesting under other circumstances, in its sole discretion. 

 Forfeiture of Performance RSUs. Except in connection with a Retirement below, Performance RSUs which
are not or do not become vested upon your termination of employment for any reason shall, coincident therewith, be forfeited and be of no force and effect. 
 In the event you terminate employment prior to the third anniversary of the Date of Grant due to Retirement, 25% of the Initial Performance RSUs will remain in effect provided your termination date is on
or after the first anniversary of the Date of Grant but prior to the second anniversary, and 50% of the Initial Performance RSUs will remain in effect provided your termination date is on or after the second anniversary of the Date of Grant but
prior to the third anniversary. The number of Performance RSUs that will vest pursuant to the preceding sentence will be determined by multiplying (a) the total number of Performance RSUs that would have vested under this Agreement based on
actual performance had you remained employed until the third anniversary of the Date of Grant by (b) the applicable percentage from the preceding sentence. 
 For purposes of this Agreement, “Retirement” means a voluntary termination of employment after attaining age 60 and completing 10 years of service with B&W, or an involuntary termination due
to a reduction in force. For purposes of this Agreement, a reduction in force shall mean a termination of employment due to elimination of a previously required position or previously required services, or due to the consolidation of departments,
abandonment of plants or offices, technological change or declining business activities, where such termination is intended to be permanent; or under other circumstances which the Committee, in accordance with standards uniformly applied with
respect to all similarly situated employees, designates as a reduction in force. 
 In the event that (a) you are convicted of (i) a
felony or (ii) a misdemeanor involving fraud, dishonesty or moral turpitude, or (b) you engage in conduct that adversely affects or may reasonably be expected to adversely affect the business reputation or economic interests of B&W, as
determined in the sole judgment of the Committee, then all Performance RSUs and all rights or benefits awarded to you under this grant of Performance RSUs are forfeited, terminated and withdrawn immediately upon such conviction or notice of such
determination. The Committee shall have the right to suspend any and all rights or benefits awarded to you hereunder pending its investigation and final determination with regard to such matters. The forfeiture provisions of this paragraph are in
addition to the paragraphs under the heading “Clawback Provisions” below. 
 Number of Performance RSUs. Except as otherwise
provided in this Agreement and subject to adjustments permitted by the Plan, the number of Performance RSUs in which you will vest under this Agreement, if any, will be determined by multiplying (a) one-half of the sum of (i) the vested
percentage applicable to Return on Invested Capital (“ROIC”) plus (ii) the vested percentage applicable to diluted Earnings Per Share (“EPS”) by (b) the number of Initial Performance RSUs. The maximum number of
Performance RSUs in which you can vest is 200% of your Initial Performance RSUs and the minimum number of Performance RSUs in which you can vest is 0% of your Initial Performance RSUs. 

  
 - 2 -

 The vested percentage applicable to ROIC and EPS will each be determined over the Performance Period as
illustrated in the schedules set forth below. For purposes of this Agreement, the “Performance Period” means the period beginning on January 1, 2013 and ending on December 31, 2015. 

Calculating ROIC and EPS. Except as otherwise described below, the component values used to calculate ROIC and EPS will be determined in
accordance with U.S. generally accepted accounting principles excluding (1) any changes in accounting standards imposed on or adopted by B&W after the Date of Grant, (2) the expenses related to the implementation of B&W’s
Global Competitiveness Initiative, (3) any pension accounting mark-to-market adjustment and (4) all acquisition expenses for any transaction with expenses exceeding $5 million. 

Return on Invested Capital (ROIC) 
 The vested percentage applicable to ROIC will be determined based on B&W’s average annual ROIC (as calculated below) (“Average ROIC”) for the Performance Period in accordance
with the following schedule: 
  

					
	 Average ROIC
	  	ROIC Vested Percentage	 
	 [insert threshold ROIC]
	  	 	50	% 
	 [insert target ROIC]
	  	 	100	% 
	 [insert maximum ROIC]
	  	 	200	% 

 Vested percentages between the amounts shown will be calculated by linear interpolation. The vested percentage applicable
to ROIC will be 0% if the Average ROIC for the Performance Period is below [insert threshold]%. In no event will the vested percentage applicable to ROIC be greater than 200%. 
 ROIC will be calculated quarterly and the ROIC for any calendar year during the Performance Period will equal the sum of the four applicable quarterly ROIC calculations. Average ROIC will equal the sum of
the three annual ROIC calculations during the Performance Period divided by three. 
 For purposes of this Agreement, the term “ROIC”
is a ratio measure of B&W’s net income in relation to B&W’s invested capital, using the formula set forth below. For purposes of determining ROIC, net income is pre-tax income less tax expense. Tax expense will be based on
B&W’s normal, weighted average effective tax rate for the jurisdictions in which it is operating for the applicable periods. Invested capital is B&W’s total assets less current liabilities. Current liabilities include any
liabilities that are due within one calendar year and will be defined based on B&W’s consolidated balance sheet applicable to the applicable period. 
  

 

  
 - 3 -

 For purposes of the ROIC calculation: Net Income will exclude mPower development expenses (less applicable
taxes) and Invested Capital will include cumulative mPower development expenses from January 1, 2011 through the end of the Performance Period. mPower development expenses is defined below. 

Diluted Earnings Per Share (EPS) 
 The vested percentage applicable to EPS will be determined based on B&W’s cumulative EPS (as calculated below) (“Cumulative EPS”) for the Performance Period in accordance with the
following schedule: 
  

					
	 Cumulative EPS
	  	EPS Vested Percentage	 
	 [insert threshold EPS]
	  	 	50	% 
	 [insert target EPS]
	  	 	100	% 
	 [insert maximum EPS]
	  	 	200	% 

 Vested percentages between the amounts shown will be calculated by linear interpolation. The vested percentage applicable
to EPS will be 0% if the Cumulative EPS for the Performance Period is below $[insert threshold EPS]. In no event will the vested percentage applicable to EPS be greater than 200%. 
 EPS will be calculated for each calendar year during the Performance Period and Cumulative EPS for the Performance Period will equal the sum of the three applicable annual EPS calculations. 

For purposes of this Agreement, the term “EPS” means B&W’s net income attributable to stockholders of common stock excluding
mPower development expenses (less applicable taxes) for the applicable period divided by B&W’s weighted average diluted shares outstanding for the applicable period. For purposes of determining EPS, net income attributable to stockholders
of common stock is defined as “Net Income Attributable to The Babcock & Wilcox Company” on B&W’s Consolidated Statement of Income. Diluted shares outstanding will include all basic shares outstanding and any other
dilutive securities for the period. If any securities are dilutive, the impact on the number of outstanding shares will be included in the denominator and the related income statement impact of the security will be removed from the numerator.

  
 

 
 WACSO represents weighted average common stock outstanding. 
 For purposes of this Agreement, “mPower development expenses” includes all expenses related to the research and development of mPower plus any applicable selling, general and
administrative expenses and any associated operating income. If mPower produces any associated operating income, such operating income will act to reduce the amount of mPower development expenses. 

  
 - 4 -

 Settlement of Performance RSUs. You (or your beneficiary, if applicable) will receive one share of
B&W common stock for each Performance RSU that vests under this Agreement. Shares shall be distributed as soon as administratively practicable after the Settlement Date, but in no event later than March 15 following the end of the calendar
year in which the Settlement Date occurs. For purposes of this Agreement, “Settlement Date” means either: (a) the applicable Vesting Date or, in the event you made a permitted deferral election pursuant to the Plan with respect
to this grant, (b) the date(s) of the applicable distribution event in accordance with such deferral election. 
 Dividend, Voting
Rights and Other Rights. You shall have no rights of ownership in the shares of B&W common stock underlying the Performance RSUs and shall have no right to vote such shares until the date on which the shares are transferred to you pursuant
hereto. To the extent that cash dividends are otherwise paid with respect to shares of B&W common stock, dividend equivalents will be credited with respect to the shares underlying the Performance RSUs and shall be deferred (with no earnings
accruing) until and paid contingent upon the vesting of the related Performance RSUs and paid at the same time the underlying shares are transferred to you. 
 Taxes 
 You will realize income in connection with this Performance RSUs grant in
accordance with the tax laws of the jurisdiction that is applicable to you. You should consult your tax advisor as to the federal and/or state income tax consequences associated with this Performance Share grant as it relates to your specific
circumstances. 
 By acceptance of this letter, you agree that any amount which B&W is required to withhold on your behalf, including state
income tax and FICA withholding, in connection with income realized by you under this grant or as otherwise required under applicable law will be satisfied by withholding whole units or shares having an aggregate fair market value as near equal in
value but not exceeding the amount of such required tax withholding, unless the Committee determines to satisfy the statutory minimum withholding obligation by another method permitted by the Plan. 

Regardless of the withholding method, you will promptly pay to B&W the amount of income tax which B&W is required to withhold in connection with
the income realized by you in connection with this grant and, unless prohibited by applicable law, that you hereby authorize B&W to withhold such amount, in whole or in part, from subsequent salary payments, without further notice to you.

 Transferability 
 Performance RSUs granted hereunder are non-transferable other than by will or by the laws of descent and distribution or pursuant to a qualified domestic relations order. 

  
 - 5 -

 Securities and Exchange Commission Requirements 

If you are a Section 16 insider, this grant of Performance RSUs is not reportable on a Form 4 unless and until they become
vested. At that time, the number of Performance RSUs ultimately awarded to you must be reported on a Form 4 before the end of the second (2nd) business day following the Vesting Date, as applicable. Please be aware that if you are going to reject the
grant, you should do so immediately after the Date of Grant. Please advise Kathy Peres or Angie Winter immediately by e-mail, fax or telephone if you intend to reject this grant. 
 Those of you covered by these requirements will have already been advised of your status. Others may become Section 16 insiders at some future date, in which case reporting will be required in the
same manner noted above. If Section 16 applies to you, you are also subject to Rule 144. This Rule is applicable only when the shares are sold, so you need not take any action under Rule 144 at this time. 

Clawback Provisions 
 Recovery of Performance RSUs. In the event that B&W is required to prepare an accounting restatement due to the material noncompliance of B&W with any financial reporting requirement under
the U.S. federal securities laws as a result of fraud (a “Restatement”) and the Board reasonably determines that you knowingly engaged in the fraud, B&W will have the right to recover the Performance RSUs granted during the
three-year period preceding the date on which the Board or B&W, as applicable, determines it is required to prepare the Restatement (the “Three-Year Period”), or vested in whole or in part during the Three-Year Period, to the
extent of any excess of what would have been granted to or would have vested for you under the Restatement. 
 Recovery Process. In the
event a Restatement is required, the Board, based upon a recommendation by the Committee, will (a) review the Performance RSUs either granted or vested in whole or in part during the Three-Year Period and (b) in accordance with the
provisions of this Agreement and the Plan, will take reasonable action to seek recovery of the amount of such Performance RSUs in excess of what would have been granted to or would have vested for you under the Restatement (but in no event more than
the total amount of such Performance RSUs), as such excess amount is reasonably determined by the Board in its sole discretion, in compliance with Section 409A of the Code. There shall be no duplication of recovery under Article 19 of the Plan
and any of 15 U.S.C. Section 7243 (Section 304 of The Sarbanes-Oxley Act of 2002) and Section 10D of the Exchange Act. 

Other Information 

Neither the action of B&W in establishing the Plan, nor any action taken by it, by the Committee or by your employer, nor any provision of the Plan
or this Agreement shall be construed as conferring upon you the right to be retained in the employ of B&W or any of its subsidiaries or affiliates. 

  
 - 6 -EX-10.10

 Exhibit 10.10 
 SECOND AMENDMENT 
 TO 

SUBLEASE AGREEMENT 
  

	Date:	November 12, 2012 

  

	Sublessor:	DEL WEBB CORPORATION, a Delaware corporation 

  

	Sublessee:	SPECTRUM PHARMACEUTICALS, INC, a Delaware corporation 

 RECITALS 
  

	 	A.	Sublessor and Sublessee previously entered into that certain Sublease Agreement dated as of December 2, 2010, as amended by that certain First Amendment To
Sublease Agreement, dated November 16, 2011 (collectively, the “Sublease”). 

  

	 	B.	Defined terms appear in this Second Amendment to Sublease Agreement (this “Second Amendment”) with the first letter of each word in the term
capitalized. Unless otherwise defined herein, defined terms appearing in this Second Amendment shall have the meanings attributed to them in the Sublease. 

  

	 	C.	Sublessor and Sublessee agree that the Sublease Premises shall be increased to include Suite 200 totaling approximately 2670 rentable square feet on the second floor
shown on Attachment 1 attached to this Second Amendment (“Additional Space”), all upon the terms and conditions in the Sublease and this Second Amendment. 

AGREEMENT 
 THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Sublessor and Sublessee agree as follows: 
  

	 	1.	Each of the recitals set forth above are hereby incorporated herein by this reference and are made a part hereof. 

 

	 	2.	Notwithstanding anything to the contrary contained in the Sublease, Sublessor and Sublessee agree as follows: 

 

	 	(i)	The Additional Space shall become part of the Sublease Premises on November 15, 2012 (“Additional Space Commencement Date”), subject to all the
terms and conditions of the Sublease; 

	 	(ii)	Beginning on the Additional Space Commencement Date, the Base Rent for the Additional Space shall be as follows: 

 

	 	(a)	Beginning on the Additional Space Commencement Date through May 31, 2013, the Base Rent for the Additional Space shall be Four Thousand Five and 00/100 Dollars
($4,005.00) per month. 

  

	 	(b)	Commencing on June 1, 2013, through April 30, 2014, the Base Rent for the Additional Space shall be Four Thousand One Hundred Thirty-Eight and 50/100 Dollars
($4,138.50) per month. 

  

	 	(iii)	Sublessee has inspected the Additional Space and accepts it in its “AS-IS” condition. 

 

	 	(iv)	Sublessee shall pay to Sublessor upon the execution of this Second Amendment an amount equal to Four Thousand Five and 00/100 Dollars ($4,005.00) for the Base Rent due
for the Additional Space; 

  

	 	(vi)	Sublessee shall not have to increase the existing Security Deposit for the Additional Space; and 

 

	 	(vii)	Effective on the Additional Space Commencement Date, Exhibit A attached to the Sublease shall be replaced and superseded by Exhibit A attached to this Second Amendment,
which shall show all the space being sublet by Sublessee from Sublessor. 

  

	 	3.	This Second Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Any or all parties may execute this Second Amendment by facsimile signature, or by email with an attached executed pdf of the Second Amendment, and any such facsimile signature, or pdf delivered by email, shall be deemed an original
signature. 

  

	 	4.	The Sublease, as amended and supplemented hereby by this Second Amendment, is hereby ratified, confirmed, and approved, and shall remain in full force and effect.

 IN WITNESS WHEREOF, Sublessor and Sublessee have executed this Second Amendment as of the date first written
above. 
  

			
	 SUBLESSOR:

	
	 DEL WEBB CORPORATION, a

Delaware corporation

		
	 By:
	 	 /s/ Gregory M. Nelson

	 Name:
	 	 Gregory M. Nelson

	 Its:
	 	 V.P.

	
	 SUBLESSEE:

	
	 SPECTRUM PHARMACEUTICALS, INC,

a Delaware corporation

		
	 By:
	 	 /s/ Brett L. Scott

	 Name:
	 	 Brett L. Scott

	 Its:
	 	 Senior V.P., Acting CFO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]